Live Breaking News & Updates on Shane ponraj

Stay informed with the latest breaking news from Shane ponraj on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Shane ponraj and stay connected to the pulse of your community

The 10 Best-Performing Undervalued Moat Stocks

Interactive Brokers and Verizon are among the recent top undervalued stocks with long-term competitive advantages.

United-states , New-york , Berkshire , China , America , Chinese , Michael-wong , Greggory-warren , Shane-ponraj , Ali-mogharabi , Stuart-weitzman , Warren-buffett

Chemist Warehouse: Bullish investors say Sigma tie-up could be next Domino's or Bunnings

Investors are optimistic that the pharmacy chain is among the best retailers in the country, and has enough room to grow at home to justify its valuation.

Australia , Australian , Mario-verrocchi , Luke-mcmillan , Morningstar-shane-ponraj , Consumer-commission , Pharmacy-guild , Chemist-warehouse , Ophir-asset-management , Cyan-asset-management , Sam-gance , Shane-ponraj

Sigma Healthcare could shed customers after Chemist Warehouse merger

The deal, creating an $8.8 billion retail and wholesaling giant, could even be blocked by competition regulators, according to analysts at Morningstar.

New-zealand , Australia , Melbourne , Victoria , Australian , Shane-ponraj , Zealand-overseas-investment-office , Consumer-commission , Pharmacy-guild , Discount-drug-stores , Australian-competition , Overseas-investment

Australia's CSL tanks as Novo Nordisk's kidney trial success stokes competition concerns

Shares of biotechnology firm CSL fell to a four-year low on Thursday, after rival Novo Nordisk's Ozempic drug showed early signs of success in delaying the progression of kidney disease in...

Australia , Bengaluru , Karnataka , India , Denmark , Danish , Australian , Shane-ponraj , Tim-waterer , Archishma-iyer , Novo-nordisk , Sonic-healthcare

Top Stock Gainers and Losers of August 2023

Apellis, Arista Networks, and Eli Lilly stocks advance, while Insulet, SolarEdge Technologies, and Roblox stocks decline.

Australia , Texas , United-states , Zoominfo-technologies , Neil-macker , Debbies-wang , Apellis-pharmaceuticals , Brett-castelli , Damien-conover , Shane-ponraj , Brett-horn , Morningstar-horn

BKL ASX: Kirin's $1.9 billion bid for vitamins group Blackmores could face a 'wild card' in gaining approval for selling into China.

But equities analysts do not expect a rival offer to Kirin’s $95 per share bid to emerge, nor for local regulators to intervene in the buyout.

China , Japan , Sydney , New-south-wales , Australia , New-zealand , Japanese , Chinese , Australian , Shane-ponraj , Glenn-cochran , Sophie-carran

Japan's Kirin Agrees $1.2bn For Australian Vitamin Maker Blackmores

Japanese drinks giant Kirin Holdings Co Ltd has agreed a $1.2 billion buyout of Australian vitamin maker Blackmores Ltd, furthering a diversification push while...

Japan , Australia , China , Tokyo , Chinese , Nippon , Japanese , Australian , Mio-kato , Shane-ponraj , Marcus-blackmore , Takeshi-minakata

Is ResMed a buy>

Ventilator and sleep products maker ResMed has been on a rollercoaster two years. Are its shares a good buy after their recent price falls?

Germany , German , Craig-wong-pan , Shane-ponraj , Mick-farrell , Medifox-dan , Peterc-farrell , David-low , Philips , Shane-storey ,

Is ResMed a buy>

Ventilator and sleep products maker ResMed has been on a rollercoaster for two years. Are its shares a good buy after their recent price falls?

Germany , German , Craig-wong-pan , Shane-ponraj , Mick-farrell , Medifox-dan , Peterc-farrell , David-low , Philips , Shane-storey ,